BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11956152)

  • 1. Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3/L1 adipocytes.
    Standaert ML; Kanoh Y; Sajan MP; Bandyopadhyay G; Farese RV
    Endocrinology; 2002 May; 143(5):1705-16. PubMed ID: 11956152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes.
    Miura A; Sajan MP; Standaert ML; Bandyopadhyay G; Kahn CR; Farese RV
    Biochemistry; 2004 Dec; 43(49):15503-9. PubMed ID: 15581362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.
    Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
    Endocrinology; 2001 Apr; 142(4):1595-605. PubMed ID: 11250941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane localization of 3-phosphoinositide-dependent protein kinase-1 stimulates activities of Akt and atypical protein kinase C but does not stimulate glucose transport and glycogen synthesis in 3T3-L1 adipocytes.
    Egawa K; Maegawa H; Shi K; Nakamura T; Obata T; Yoshizaki T; Morino K; Shimizu S; Nishio Y; Suzuki E; Kashiwagi A
    J Biol Chem; 2002 Oct; 277(41):38863-9. PubMed ID: 12147684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione treatment enhances insulin effects on protein kinase C-zeta /lambda activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats.
    Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
    J Biol Chem; 2000 Jun; 275(22):16690-6. PubMed ID: 10749857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes.
    Miura A; Sajan MP; Standaert ML; Bandyopadhyay G; Franklin DM; Lea-Currie R; Farese RV
    Biochemistry; 2003 Dec; 42(48):14335-41. PubMed ID: 14640702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation.
    Venable CL; Frevert EU; Kim YB; Fischer BM; Kamatkar S; Neel BG; Kahn BB
    J Biol Chem; 2000 Jun; 275(24):18318-26. PubMed ID: 10751417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
    Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
    J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes.
    Standaert ML; Sajan MP; Miura A; Bandyopadhyay G; Farese RV
    Biochemistry; 2004 Dec; 43(49):15494-502. PubMed ID: 15581361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport.
    Staubs PA; Nelson JG; Reichart DR; Olefsky JM
    J Biol Chem; 1998 Sep; 273(39):25139-47. PubMed ID: 9737973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C-lambda knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport.
    Bandyopadhyay G; Standaert ML; Sajan MP; Kanoh Y; Miura A; Braun U; Kruse F; Leitges M; Farese RV
    Mol Endocrinol; 2004 Feb; 18(2):373-83. PubMed ID: 14615604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity.
    Bazuine M; Ouwens DM; Gomes de Mesquita DS; Maassen JA
    Eur J Biochem; 2003 Oct; 270(19):3891-903. PubMed ID: 14511371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
    Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
    Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
    Sakoda H; Ogihara T; Anai M; Funaki M; Inukai K; Katagiri H; Fukushima Y; Onishi Y; Ono H; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Diabetes; 2000 Oct; 49(10):1700-8. PubMed ID: 11016454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
    Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
    Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.
    Whiteman EL; Chen JJ; Birnbaum MJ
    Endocrinology; 2003 Sep; 144(9):3811-20. PubMed ID: 12933652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.
    Smith U; Gogg S; Johansson A; Olausson T; Rotter V; Svalstedt B
    FASEB J; 2001 Jan; 15(1):215-220. PubMed ID: 11149909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
    Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
    Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.
    Jiang ZY; Zhou QL; Holik J; Patel S; Leszyk J; Coleman K; Chouinard M; Czech MP
    J Biol Chem; 2005 Jun; 280(22):21622-8. PubMed ID: 15799971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.